Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Sarah Wakeman, MD, FASAM
Contributor
Dr. Sarah Wakeman is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team and a clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate of the American Board of Addiction Medicine. She is secretary for the Massachusetts Society of Addiction Medicine and chair of the policy committee. She previously served on Governor Baker’s Opioid Addiction Working Group.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her active research projects include a study evaluating the impact of addiction consultation on hospitalized medical patients with substance use disorder; a qualitative study exploring the role of recovery coaches for patients with substance use disorder; the healthcare cost and utilization impact of increased addiction treatment services across a health system; and the impact of a hospital-wide substance use disorder initiative on physician attitudes, preparedness, and clinical practice related to substance use disorder.
Posts by Sarah Wakeman, MD, FASAM
Sarah Wakeman, MD, FASAM
Lofexidine: Another option for withdrawal from opioids, but is it better?
Sarah Wakeman, MD, FASAM
Saving lives by prescribing naloxone with opioid painkillers
Sarah Wakeman, MD, FASAM
Fentanyl: The dangers of this potent “man-made” opioid
Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions